SEC Form 4	Date	Sym	Company	Insider	Title	Shares	Transaction	Value
DMay 9 09:36pm	May 9 2013	ICPT	Intercept Pharmaceuticals Inc	Silverstein Jonathan	Director, 10% Owner	324	Option exercise at $0.00	$0
DMay 9 09:36pm	May 7 2013	ICPT	Intercept Pharmaceuticals Inc	Silverstein Jonathan	Director, 10% Owner	1,330	Grant at $0.00	$0
DApr 11 09:52pm	Apr 9 2013	ICPT	Intercept Pharmaceuticals Inc	Silverstein Jonathan	Director, 10% Owner	649	Option exercise at $0.00	$0
DOct 16 2012	Oct 16 2012	ICPT	Intercept Pharmaceuticals Inc	Silverstein Jonathan	Director, 10% Owner	1,817,300	Converted deriv at $0.00	$0
DOct 16 2012	Oct 16 2012	ICPT	Intercept Pharmaceuticals Inc	Silverstein Jonathan	Director, 10% Owner	333,334	Purchase at $15.00	$5,000,010
DMay 18 2007	May 18 2007	PODD	Insulet Corp	Silverstein Jonathan	Director	1,568,841	Converted deriv at $0.00	$0
Mar 5 2007	MMar 1 2007	AVNR	Avanir Pharmaceuticals	Silverstein Jonathan	Director	44,248	Grant at $0.00	$0
AJun 8 2006	MMay 31 2006	AVNR	Avanir Pharmaceuticals	Silverstein Jonathan	Director	629,469	Other Sale at $9.79	$6,162,502
Jun 7 2006	May 31 2006	AVNR	Avanir Pharmaceuticals	Silverstein Jonathan	Director	629,121	Sale at $9.79	$6,159,095
Jun 7 2006	May 31 2006	AVNR	Avanir Pharmaceuticals	Silverstein Jonathan	Director	348	Other Purchase at $9.79	$3,407
Feb 15 2006	Feb 13 2006	AVN	Avanir Pharmaceuticals	Silverstein Jonathan	Director	6,435	Grant at $0.00	$0
Oct 24 2005	Oct 20 2005	AVN	Avanir Pharmaceuticals	Silverstein Jonathan	Director	566,038	Purchase at $2.65	$1,500,001
Apr 12 2005	Apr 8 2005	AVN	Avanir Pharmaceuticals	Silverstein Jonathan	Director	900,000	Purchase at $2.20	$1,980,000

^A Amended filing
^D Derivative transaction exists
^M Multiple transactions summarized; earliest reported transaction date and average weighted transaction price
Yahoo Finance